Medication info
Candesartan Cilexetil 80/12.5 mg Tablet

Candesartan Cilexetil 80/12.5 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Valsartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Yuhan Corporation
Appearance
Bright orange oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 200808328 · Notified 2008.07.30 · Insurance code 642103970

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Yuhan Corporation

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine is used to manage blood pressure effectively through additional treatment when blood pressure is not sufficiently controlled with monotherapy due to essential hypertension.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg to lower blood pressure. The blood pressure-lowering effect reaches its maximum after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance of 30 mL/min or higher). ○ Patients with hepatic impairment In patients with mild to moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medication can cause serious harm to the fetus, particularly in the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to this drug or its components, or with certain severe liver or kidney disorders, should not take this medication. Caution is advised when administering this drug to patients with electrolyte imbalances or impaired kidney function, and it should be used with particular caution in elderly patients or those with heart disease. The hydrochlorothiazide component may increase sensitivity to sunlight, raising the risk of skin cancer, so sun exposure should be avoided, and any unusual signs should be discussed with a doctor immediately. Dizziness or drowsiness may occur during treatment, requiring caution when driving or operating machinery. Potassium supplements or potassium-containing medications should not be taken without consulting a doctor, and serum electrolyte levels should be monitored regularly. Patients with reduced kidney or liver function should undergo functional testing before and after taking this drug, and dosage adjustments may be necessary if required. There may be interactions with other drugs, so it is essential to inform your doctor or pharmacist of any medications being taken. Overdosage may lead to hypotension, dizziness, arrhythmias, and the patient should seek medical attention immediately. The safety of this medication has not been established in children, so it should be administered to pediatric patients with caution. During storage, keep this medicine out of reach of children, away from moisture, and keep it in its original container.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory infection, diarrhea, joint pain, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, respiratory distress, erectile dysfunction, enteritis, hyperhidrosis, sensory decrease, insomnia, hypokalemia, hypotension, influenza, muscle cramps, myalgia, nausea, nasal congestion, nasal hemorrhage, throat pain, otitis media, limb pain, paresthesia, throat and neck pain, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament sprain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, vascular edema, itching, serum sickness, vasculitis, hair loss, kidney function impairment, myalgia, symptoms resembling anaphylaxis, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, flare of systemic lupus erythematosus, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, decreased hemoglobin, thrombocytopenia, increased serum potassium, dizziness, vasculitis, elevated liver function tests, vascular edema, rash, vesicular dermatitis, renal failure, hypokalemia, elevated blood lipids, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, urticaria, skin rash, photosensitivity reactions, necrotizing vasculitis, erythematosus lupus, loss of appetite, nausea, vomiting, abdominal discomfort, constipation, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmia, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, leukopenia, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, hypersensitivity reactions, pneumonia, pulmonary edema, joint pain, weakness, low back pain, insomnia, decreased libido, nausea, pharyngitis, rhinitis, sinusitis, upper respiratory infection, acute angle-closure glaucoma, choroidal effusion, nausea, drowsiness, hypovolemia, arrhythmia, muscle cramps, hypotension, tachycardia, ECG changes due to hypokalemia, muscle weakness, incomplete paralysis, increased serum uric acid levels, gout, decreased serum protein-bound iodine levels, acute transient myopia, acute angle-closure glaucoma, choroidal effusion, acute respiratory distress syndrome, pulmonary edema, respiratory distress, fever, deterioration of lung condition, hypotension, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. Additionally, it is important to store it in a cool place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

Bright orange oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.